Latest news with #SEK1.99B
Yahoo
23-04-2025
- Business
- Yahoo
European Penny Stocks To Consider In April 2025
As the European markets rebound with notable gains following the ECB's decision to cut rates amid trade uncertainties, investor sentiment has been buoyed across major indices. For those looking beyond established giants, penny stocks—typically representing smaller or newer companies—offer intriguing opportunities. Despite being an outdated term, penny stocks continue to capture interest for their potential growth at lower price points, particularly when they boast strong balance sheets and solid fundamentals. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.08 SEK1.99B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.50 SEK228.66M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.57 SEK267.7M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.90 SEK237.27M ★★★★★★ IMS (WSE:IMS) PLN3.61 PLN122.36M ★★★★☆☆ FAE Technology (BIT:FAE) €2.35 €47.06M ★★★★☆☆ Cellularline (BIT:CELL) €2.53 €53.36M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.9899 €33.15M ★★★★★★ Arcure (ENXTPA:ALCUR) €4.06 €23.51M ★★★★☆☆ Deceuninck (ENXTBR:DECB) €2.18 €300.98M ★★★★★★ Click here to see the full list of 433 stocks from our European Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: RCS MediaGroup S.p.A. operates as a multimedia publishing company in Italy and internationally, with a market cap of €492.55 million. Operations: RCS MediaGroup S.p.A. does not report specific revenue segments. Market Cap: €492.55M RCS MediaGroup's financial health reflects a stable position with short-term assets of €353.5 million exceeding long-term liabilities of €244.7 million, though they fall short in covering short-term liabilities of €371.4 million. The company's debt is well-covered by operating cash flow and has decreased significantly over the past five years, indicating prudent financial management. Despite a low return on equity at 14%, RCS shows robust earnings growth with an 8.8% increase last year and improved profit margins from 6.9% to 7.6%. The stock trades at a significant discount to its estimated fair value, supported by high-quality earnings and experienced management and board teams with average tenures exceeding industry norms. Unlock comprehensive insights into our analysis of RCS MediaGroup stock in this financial health report. Gain insights into RCS MediaGroup's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Oyj is an online retailer based in Finland with a market capitalization of €88.95 million. Operations: The company generates revenue primarily from its online retail segment, which accounted for €467.83 million. Market Cap: €88.95M Oyj, with a market cap of €88.95 million, operates primarily in the online retail sector, generating €467.83 million in revenue last year. Despite being unprofitable and experiencing increased losses over five years, its debt is well-covered by operating cash flow and short-term assets exceed liabilities. The company trades at 40% below estimated fair value but faces volatility concerns with a high weekly share price fluctuation and recent regulatory fines upheld by the Helsinki Administrative Court. Management is experienced; however, the board lacks tenure depth which could impact strategic direction amidst anticipated revenue growth for 2025. Take a closer look at Oyj's potential here in our financial health report. Review our growth performance report to gain insights into Oyj's future. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Getin Holding S.A. is a financial holding company involved in investment activities both in Poland and internationally, with a market cap of PLN129.80 million. Operations: The company generates revenue primarily from banking services in Ukraine, amounting to PLN157.06 million. Market Cap: PLN129.8M Getin Holding S.A., with a market cap of PLN129.80 million, has recently become profitable, marking a significant turnaround in its financial performance. The company boasts an outstanding Return on Equity of 41.3%, indicating efficient use of shareholder funds. Its earnings are considered high quality, and the Price-To-Earnings ratio of 5.1x suggests it is undervalued compared to the Polish market average. However, uncertainties remain regarding its allowance for bad loans and management tenure data is insufficient to assess experience levels fully. Despite these concerns, Getin's liabilities are primarily low-risk customer deposits, enhancing financial stability. Jump into the full analysis health report here for a deeper understanding of Getin Holding. Examine Getin Holding's past performance report to understand how it has performed in prior years. Unlock more gems! Our European Penny Stocks screener has unearthed 430 more companies for you to here to unveil our expertly curated list of 433 European Penny Stocks. Seeking Other Investments? Rare earth metals are the new gold rush. Find out which 23 stocks are leading the charge. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:RCS HLSE:VERK and WSE:GTN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
23-04-2025
- Business
- Yahoo
European Penny Stocks To Consider In April 2025
As the European markets rebound with notable gains following the ECB's decision to cut rates amid trade uncertainties, investor sentiment has been buoyed across major indices. For those looking beyond established giants, penny stocks—typically representing smaller or newer companies—offer intriguing opportunities. Despite being an outdated term, penny stocks continue to capture interest for their potential growth at lower price points, particularly when they boast strong balance sheets and solid fundamentals. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.08 SEK1.99B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.50 SEK228.66M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.57 SEK267.7M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.90 SEK237.27M ★★★★★★ IMS (WSE:IMS) PLN3.61 PLN122.36M ★★★★☆☆ FAE Technology (BIT:FAE) €2.35 €47.06M ★★★★☆☆ Cellularline (BIT:CELL) €2.53 €53.36M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.9899 €33.15M ★★★★★★ Arcure (ENXTPA:ALCUR) €4.06 €23.51M ★★★★☆☆ Deceuninck (ENXTBR:DECB) €2.18 €300.98M ★★★★★★ Click here to see the full list of 433 stocks from our European Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: RCS MediaGroup S.p.A. operates as a multimedia publishing company in Italy and internationally, with a market cap of €492.55 million. Operations: RCS MediaGroup S.p.A. does not report specific revenue segments. Market Cap: €492.55M RCS MediaGroup's financial health reflects a stable position with short-term assets of €353.5 million exceeding long-term liabilities of €244.7 million, though they fall short in covering short-term liabilities of €371.4 million. The company's debt is well-covered by operating cash flow and has decreased significantly over the past five years, indicating prudent financial management. Despite a low return on equity at 14%, RCS shows robust earnings growth with an 8.8% increase last year and improved profit margins from 6.9% to 7.6%. The stock trades at a significant discount to its estimated fair value, supported by high-quality earnings and experienced management and board teams with average tenures exceeding industry norms. Unlock comprehensive insights into our analysis of RCS MediaGroup stock in this financial health report. Gain insights into RCS MediaGroup's historical outcomes by reviewing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Oyj is an online retailer based in Finland with a market capitalization of €88.95 million. Operations: The company generates revenue primarily from its online retail segment, which accounted for €467.83 million. Market Cap: €88.95M Oyj, with a market cap of €88.95 million, operates primarily in the online retail sector, generating €467.83 million in revenue last year. Despite being unprofitable and experiencing increased losses over five years, its debt is well-covered by operating cash flow and short-term assets exceed liabilities. The company trades at 40% below estimated fair value but faces volatility concerns with a high weekly share price fluctuation and recent regulatory fines upheld by the Helsinki Administrative Court. Management is experienced; however, the board lacks tenure depth which could impact strategic direction amidst anticipated revenue growth for 2025. Take a closer look at Oyj's potential here in our financial health report. Review our growth performance report to gain insights into Oyj's future. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Getin Holding S.A. is a financial holding company involved in investment activities both in Poland and internationally, with a market cap of PLN129.80 million. Operations: The company generates revenue primarily from banking services in Ukraine, amounting to PLN157.06 million. Market Cap: PLN129.8M Getin Holding S.A., with a market cap of PLN129.80 million, has recently become profitable, marking a significant turnaround in its financial performance. The company boasts an outstanding Return on Equity of 41.3%, indicating efficient use of shareholder funds. Its earnings are considered high quality, and the Price-To-Earnings ratio of 5.1x suggests it is undervalued compared to the Polish market average. However, uncertainties remain regarding its allowance for bad loans and management tenure data is insufficient to assess experience levels fully. Despite these concerns, Getin's liabilities are primarily low-risk customer deposits, enhancing financial stability. Jump into the full analysis health report here for a deeper understanding of Getin Holding. Examine Getin Holding's past performance report to understand how it has performed in prior years. Unlock more gems! Our European Penny Stocks screener has unearthed 430 more companies for you to here to unveil our expertly curated list of 433 European Penny Stocks. Seeking Other Investments? Rare earth metals are the new gold rush. Find out which 23 stocks are leading the charge. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:RCS HLSE:VERK and WSE:GTN. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
22-04-2025
- Business
- Yahoo
European Penny Stocks Under €20M Market Cap: 3 Picks To Consider
As European markets experience a resurgence, buoyed by the European Central Bank's rate cuts and improved investor sentiment, opportunities are emerging for those willing to explore beyond traditional investments. Penny stocks, despite their vintage moniker, continue to offer intriguing prospects for growth by focusing on smaller or newer companies that often fly under the radar. In this article, we explore three penny stocks that demonstrate financial resilience and potential for long-term value. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.08 SEK1.99B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.63 SEK239.53M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.66 SEK274.45M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.80 SEK231.19M ★★★★★★ IMS (WSE:IMS) PLN3.60 PLN122.02M ★★★★☆☆ FAE Technology (BIT:FAE) €2.27 €45.46M ★★★★☆☆ Cellularline (BIT:CELL) €2.51 €52.94M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.98 €32.82M ★★★★★★ Arcure (ENXTPA:ALCUR) €4.03 €23.33M ★★★★☆☆ Deceuninck (ENXTBR:DECB) €2.15 €296.84M ★★★★★★ Click here to see the full list of 430 stocks from our European Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Websolute S.p.A. is a digital company based in Italy with a market capitalization of €11.87 million. Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to €23.84 million. Market Cap: €11.87M Websolute S.p.A., with a market capitalization of €11.87 million, has shown recent profitability, reporting net income of €0.5 million for 2024 after a previous loss. The company's revenue increased to €24.11 million from the prior year, indicating growth in its Internet Software & Services segment. Despite this progress, Websolute faces challenges such as high debt levels and low return on equity at 11.6%. The dividend yield of 3.15% is not well covered by free cash flows, and the stock remains highly volatile compared to other Italian stocks, though it trades significantly below estimated fair value. Click to explore a detailed breakdown of our findings in Websolute's financial health report. Explore Websolute's analyst forecasts in our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Petrolia SE, with a market cap of NOK234.66 million, sells and rents energy service equipment to the energy industry across Norway, Europe, Asia, and Australia. Operations: The company generates revenue of $53.47 million from its energy service segment, which involves selling and renting equipment to the energy industry. Market Cap: NOK234.66M Petrolia SE, with a market cap of NOK234.66 million, has demonstrated significant earnings growth, with an 87.6% increase over the past year, outpacing the Energy Services industry average. The company reported net income of US$3.77 million for 2024, up from US$2.01 million the previous year, indicating improved profitability and high-quality earnings. Despite its low return on equity at 7.2%, Petrolia maintains a strong financial position with more cash than debt and adequate coverage of liabilities by short-term assets valued at $35M. The stock trades well below its estimated fair value but remains highly volatile. Navigate through the intricacies of Petrolia with our comprehensive balance sheet health report here. Gain insights into Petrolia's past trends and performance with our report on the company's historical track record. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Rank Progress S.A. is engaged in investing in, developing, renting, and selling commercial real estate properties both in Poland and internationally, with a market cap of PLN167.21 million. Operations: The company's revenue is generated from two primary segments: the lease of property, contributing PLN56.41 million, and the sale of real estate, accounting for PLN97.56 million. Market Cap: PLN167.21M Rank Progress S.A., with a market cap of PLN167.21 million, has shown remarkable earnings growth of 434.3% over the past year, surpassing its 5-year average and the Real Estate industry growth rate. Despite a high net debt to equity ratio of 41.8%, its debt is well covered by operating cash flow at 24.2%. The company experienced a large one-off loss impacting recent financials, but short-term assets exceed long-term liabilities significantly. Trading at a substantial discount to its estimated fair value, Rank Progress's interest payments are well covered by EBIT, although it faces challenges with covering short-term liabilities fully. Get an in-depth perspective on Rank Progress' performance by reading our balance sheet health report here. Review our historical performance report to gain insights into Rank Progress' track record. Dive into all 430 of the European Penny Stocks we have identified here. Searching for a Fresh Perspective? These 10 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include BIT:WBS OB:PSE and WSE:RNK. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
16-04-2025
- Business
- Yahoo
April 2025 European Penny Stocks With Promising Potential
Amid escalating trade tensions and the lowest consumer sentiment in nearly three years, European markets have experienced notable volatility. Despite these challenges, the concept of penny stocks remains relevant as investors seek affordable opportunities with growth potential. Typically associated with smaller or newer companies, these stocks can offer significant upside when backed by strong financials and solid fundamentals. Name Share Price Market Cap Financial Health Rating Bredband2 i Skandinavien (OM:BRE2) SEK2.08 SEK1.99B ★★★★☆☆ Transferator (NGM:TRAN A) SEK2.64 SEK238.86M ★★★★★☆ Angler Gaming (NGM:ANGL) SEK3.60 SEK269.95M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.88 SEK236.05M ★★★★★★ IMS (WSE:IMS) PLN3.55 PLN120.32M ★★★★☆☆ FAE Technology (BIT:FAE) €2.34 €46.86M ★★★★☆☆ Cellularline (BIT:CELL) €2.51 €52.94M ★★★★★☆ Netgem (ENXTPA:ALNTG) €0.98 €32.82M ★★★★★★ Arcure (ENXTPA:ALCUR) €4.10 €23.74M ★★★★☆☆ Deceuninck (ENXTBR:DECB) €2.14 €295.46M ★★★★★★ Click here to see the full list of 425 stocks from our European Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: High Co. SA offers consumer engagement chain solutions in France, Belgium, and Spain with a market cap of €60.12 million. Operations: The company generates its revenue from advertising, amounting to €146.38 million. Market Cap: €60.12M High Co. SA, with a market cap of €60.12 million, operates in France, Belgium, and Spain offering consumer engagement solutions. Despite trading at 67% below its estimated fair value and having more cash than debt, the company faces challenges such as declining earnings forecasts over the next three years and negative earnings growth of -27.4% last year. Its net profit margins have decreased from 7.3% to 5.3%. However, recent announcements include a dividend increase to €0.25 per share for fiscal year 2024 and an exceptional dividend of €1 per share due to asset disposal income. Navigate through the intricacies of High with our comprehensive balance sheet health report here. Learn about High's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: MEMSCAP, S.A. offers micro-electro-mechanical systems (MEMS) based solutions across aerospace and defense, optical communications, medical, and biomedical sectors globally with a market cap of €30.70 million. Operations: The company's revenue is primarily derived from the aerospace segment at €8.20 million, followed by the medical sector at €3.15 million, and optical communications contributing €1.24 million. Market Cap: €30.7M MEMSCAP, S.A., with a market cap of €30.70 million, shows financial resilience despite recent challenges. The company has ample short-term assets (€11.9M) to cover both short and long-term liabilities (€3.2M and €4.3M respectively), while its debt is well covered by operating cash flow (2107.7%). However, earnings have declined over the past year (-35.8%), impacting net profit margins which fell from 15.2% to 10.9%. The company's share price remains highly volatile, and it recently delisted from OTC Equity due to inactivity but completed a share buyback of 1.34% for €0.48 million in late 2024. Get an in-depth perspective on MEMSCAP's performance by reading our balance sheet health report here. Review our growth performance report to gain insights into MEMSCAP's future. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Medivir AB (publ) is a pharmaceutical company that develops and commercializes cancer treatments in the Nordic region, Europe, and internationally, with a market cap of SEK207.51 million. Operations: The company's revenue is entirely derived from its Pharmaceuticals segment, amounting to SEK3.5 million. Market Cap: SEK207.51M Medivir AB, with a market cap of SEK207.51 million, operates in the pharmaceutical sector focusing on cancer treatments. Despite being pre-revenue with sales of just SEK3.5 million and facing a net loss of SEK123.3 million in 2024, Medivir's recent patent grant for fostroxacitabine bralpamide combined with Lenvima offers significant potential market exclusivity until 2041. The company presented promising final data from its phase 1b/2a study at the EASL Summit, showing improved outcomes in advanced liver cancer treatment. Though unprofitable and volatile, Medivir remains debt-free and has short-term assets exceeding liabilities but faces cash runway challenges under current conditions. Click to explore a detailed breakdown of our findings in Medivir's financial health report. Examine Medivir's earnings growth report to understand how analysts expect it to perform. Jump into our full catalog of 425 European Penny Stocks here. Searching for a Fresh Perspective? The end of cancer? These 23 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTPA:HCO ENXTPA:MEMS and OM:MVIR. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
14-03-2025
- Business
- Yahoo
March 2025's European Penny Stocks To Watch
As the European markets navigate the complexities of U.S. trade policy uncertainties, recent economic measures by Germany and the European Union have provided some stability amidst volatility. Penny stocks, often overlooked due to their association with smaller or newer companies, continue to offer intriguing potential for investors seeking growth at lower price points. Despite being considered a relic of past market eras, these stocks can still present significant opportunities when backed by strong financials and solid fundamentals. Name Share Price Market Cap Financial Health Rating Angler Gaming (NGM:ANGL) SEK3.70 SEK277.44M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.99 €33.15M ★★★★★★ Hifab Group (OM:HIFA B) SEK3.98 SEK242.14M ★★★★★★ High (ENXTPA:HCO) €2.67 €52.44M ★★★★★★ Transferator (NGM:TRAN A) SEK2.24 SEK210.19M ★★★★★☆ Deceuninck (ENXTBR:DECB) €2.215 €306.55M ★★★★★★ I.M.D. International Medical Devices (BIT:IMD) €1.38 €23.9M ★★★★★☆ Bredband2 i Skandinavien (OM:BRE2) SEK2.08 SEK1.99B ★★★★☆☆ Riber (ENXTPA:ALRIB) €3.04 €63.7M ★★★★★☆ IMS (WSE:IMS) PLN3.66 PLN124.05M ★★★★☆☆ Click here to see the full list of 433 stocks from our European Penny Stocks screener. Below we spotlight a couple of our favorites from our exclusive screener. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Horisont Energi AS is a clean energy company focused on producing and selling clean ammonia and hydrogen in Norway, with a market cap of NOK37.95 million. Operations: Horisont Energi AS has not reported any revenue segments. Market Cap: NOK37.95M Horisont Energi AS, with a market cap of NOK37.95 million, is pre-revenue and currently unprofitable. The company's short-term assets significantly exceed both its short-term and long-term liabilities, indicating a strong liquidity position despite having less than a year of cash runway. Recent board changes include the appointment of Frode Sigurd Berg as Chair, bringing extensive experience in strategic processes. However, the board's average tenure is under one year, suggesting limited experience. The stock has experienced high volatility recently and remains debt-free but faces challenges with declining earnings over five years. Click to explore a detailed breakdown of our findings in Horisont Energi's financial health report. Assess Horisont Energi's previous results with our detailed historical performance reports. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Isofol Medical AB is a clinical stage biotech company focused on developing, commercializing, and selling oncology drugs in Sweden and internationally, with a market cap of SEK262.95 million. Operations: Isofol Medical AB has not reported any revenue segments. Market Cap: SEK262.95M Isofol Medical AB, with a market cap of SEK262.95 million, is pre-revenue and unprofitable. The company has reduced its losses over the past five years by 27.1% annually, though recent earnings show increased losses compared to last year. Despite high volatility in share price and a new management team with limited experience (1.2 years average tenure), Isofol maintains strong liquidity as short-term assets exceed liabilities significantly, and it remains debt-free with a cash runway of over one year based on current free cash flow trends without significant shareholder dilution recently. Unlock comprehensive insights into our analysis of Isofol Medical stock in this financial health report. Learn about Isofol Medical's historical performance here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Medhelp Care Aktiebolag (publ) is a software-as-a-service company that operates a health platform focused on data-driven corporate health in Sweden and Denmark, with a market cap of SEK104.70 million. Operations: The company generates SEK91.14 million in revenue from its healthcare software segment. Market Cap: SEK104.7M Medhelp Care Aktiebolag has achieved profitability, marking a significant turnaround from previous losses. The company reported a net income of SEK2.12 million for the full year ending December 2024, compared to a net loss of SEK11.01 million the previous year, while maintaining stable revenue at SEK91.14 million. Its financial health is robust with cash exceeding total debt and short-term assets covering both short- and long-term liabilities comfortably. Despite high share price volatility, Medhelp's earnings are forecasted to grow significantly, supported by an experienced management team and board of directors with substantial tenure in their roles. Click here and access our complete financial health analysis report to understand the dynamics of Medhelp Care Aktiebolag. Gain insights into Medhelp Care Aktiebolag's outlook and expected performance with our report on the company's earnings estimates. Click this link to deep-dive into the 433 companies within our European Penny Stocks screener. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Jump on the AI train with fast growing tech companies forging a new era of innovation. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OB:HRGI OM:ISOFOL and OM:MEDHLP. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
